JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1351
PUT
Costco
COST
$409B
| $29.6M | ﹤0.01% |
59,600
-15,100
| -20% | -$7.41M |
2017 Q1
24 quarters
|
|
1352
Interparfums
IPAR
$3.6B
| $29.6M | ﹤0.01% |
208,006
+19,190
| +10% | +$2.37M |
2013 Q2
39 quarters
|
|
1353
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.4B
| $29.6M | ﹤0.01% |
1,022,246
| – | – |
2017 Q4
21 quarters
|
|
1354
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.5B
| $29.6M | ﹤0.01% |
413,490
+6,679
| +2% | +$477K |
2013 Q2
39 quarters
|
|
1355
LiveRamp
RAMP
$2.29B
| $29.5M | ﹤0.01% |
1,347,409
+192,948
| +17% | +$4.6M |
2013 Q2
39 quarters
|
|
1356
Tyson Foods
TSN
$18.2B
| $29.5M | ﹤0.01% |
497,623
+138,142
| +38% | +$8.48M |
2013 Q2
39 quarters
|
|
1357
Sonoco
SON
$4.75B
| $29.5M | ﹤0.01% |
483,820
+54,846
| +13% | +$3.25M |
2013 Q2
39 quarters
|
|
1358
Vanguard Total International Stock ETF
VXUS
$162B
| $29.5M | ﹤0.01% |
534,538
+2,728
| +0.5% | +$149K |
2015 Q4
29 quarters
|
|
1359
Cogent Communications
CCOI
$428M
| $29.4M | ﹤0.01% |
461,369
+34,591
| +8% | +$2.22M |
2015 Q1
32 quarters
|
|
1360
PTC
PTC
$21B
| $29.4M | ﹤0.01% |
229,189
+80,353
| +54% | +$10.2M |
2013 Q2
39 quarters
|
|
1361
Lennox International
LII
$12.3B
| $29.3M | ﹤0.01% |
116,512
+1,817
| +2% | +$459K |
2013 Q2
39 quarters
|
|
1362
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.52B
| $29.3M | ﹤0.01% |
824,648
+584,857
| +244% | +$21.4M |
2022 Q1
4 quarters
|
|
1363
Coherent
COHR
$64.6B
| $29.3M | ﹤0.01% |
768,659
-160,666
| -17% | -$6.54M |
2013 Q2
39 quarters
|
|
1364
Edgewell Personal Care
EPC
$1.21B
| $29.2M | ﹤0.01% |
688,266
+81,322
| +13% | +$3.41M |
2013 Q2
39 quarters
|
|
1365
Applovin
APP
$95.1B
| $29.2M | ﹤0.01% |
1,851,900
+1,789,271
| +2,857% | +$23.5M |
2021 Q2
7 quarters
|
|
|
BDN
1366
Brandywine Realty Trust
BDN
$470M
| $29M | ﹤0.01% |
6,140,715
+434,866
| +8% | +$2.55M |
2013 Q2
39 quarters
|
|
|
NBIS
1367
Nebius Group N.V.
NBIS
$64B
| $28.7M | ﹤0.01% |
1,517,159
+61
| +0% | +$1.16K |
2013 Q4
37 quarters
|
|
1368
Brown & Brown
BRO
$20.1B
| $28.7M | ﹤0.01% |
499,693
+65,699
| +15% | +$3.78M |
2013 Q2
39 quarters
|
|
1369
PUT
Salesforce
CRM
$188B
| $28.5M | ﹤0.01% |
142,900
-95,200
| -40% | -$16.1M |
2016 Q4
25 quarters
|
|
|
1370
PUT
Eli Lilly
LLY
$1.02T
| $28.5M | ﹤0.01% |
83,100
-28,900
| -26% | -$9.75M |
2016 Q3
26 quarters
|
|
1371
Belden
BDC
$4.39B
| $28.5M | ﹤0.01% |
328,338
+30,978
| +10% | +$2.57M |
2013 Q2
39 quarters
|
|
1372
Flywire
FLYW
$2.15B
| $28.4M | ﹤0.01% |
967,014
+25,608
| +3% | +$674K |
2021 Q2
7 quarters
|
|
1373
Armstrong World Industries
AWI
$6.92B
| $28.4M | ﹤0.01% |
398,312
+330,646
| +489% | +$24.8M |
2015 Q1
32 quarters
|
|
1374
Vanguard Financials ETF
VFH
$12.5B
| $28.4M | ﹤0.01% |
364,179
-269,808
| -43% | -$22.8M |
2015 Q2
31 quarters
|
|
1375
Essential Utilities
WTRG
$11B
| $28.4M | ﹤0.01% |
649,622
+179,654
| +38% | +$8.1M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.